These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2194506)

  • 41. [Hematopoietic growth factors in the prevention of infections complications in children with hematologic-oncologic diseases].
    Lehrnbecher T
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A88-102. PubMed ID: 11577368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Damage control.
    Beardsley TM
    Sci Am; 1988 Apr; 258(4):32, 36. PubMed ID: 2459771
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical use of GM-CSF in autologous bone marrow transplantation.
    Carella AM; Gaozza E; Piatti G; Giordano D; Santini G; Carlier P; Raffo MR; Nati AS; Congin A; Bacigalupo A
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():279-82. PubMed ID: 2182740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor.
    Stehle B; Weiss C; Ho AD; Hunstein W
    Blood; 1990 May; 75(9):1895-6. PubMed ID: 1970488
    [No Abstract]   [Full Text] [Related]  

  • 46. Hematopoietic growth factors in the treatment of patients with HIV infection.
    Mitsuyasu RT
    Biotherapy; 1990; 2(2):173-81. PubMed ID: 1698092
    [No Abstract]   [Full Text] [Related]  

  • 47. [Agranulocytosis treatment with rhGM-CSF].
    Rosien U; Benker G; Brittinger G; Reinwein D
    Dtsch Med Wochenschr; 1989 Nov; 114(47):1861. PubMed ID: 2684585
    [No Abstract]   [Full Text] [Related]  

  • 48. The clinical use of hematopoietic growth factors.
    Appelbaum FR
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor.
    Russo CL; Glader BE; Israel RJ; Galasso F
    Lancet; 1990 Sep; 336(8717):751-2. PubMed ID: 1975922
    [No Abstract]   [Full Text] [Related]  

  • 50. Bone marrow failure and hematopoietic growth factors.
    Douer D
    Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629
    [No Abstract]   [Full Text] [Related]  

  • 51. Colony-stimulating factor and drug-induced agranulocytosis.
    Delannoy A; Géhenot M
    Ann Intern Med; 1989 Jun; 110(11):942-3. PubMed ID: 2655524
    [No Abstract]   [Full Text] [Related]  

  • 52. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
    Nissen-Druey C
    Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
    [No Abstract]   [Full Text] [Related]  

  • 53. Preparing nurses for clinical trials: the cancer center approach.
    Wheeler VS
    Semin Oncol Nurs; 1991 Nov; 7(4):275-9. PubMed ID: 1775778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
    Yamashita J; Kawamura T; Shoin K
    No Shinkei Geka; 1990 Apr; 18(4):329-38. PubMed ID: 2197571
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.
    Gillio AP; Bonilla MA; Potter GK; Gabrilove JL; O'Reilly RJ; Souza LM; Welte K
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642
    [No Abstract]   [Full Text] [Related]  

  • 56. GM-CSF may hasten patient recovery while reducing costs.
    Oncology (Williston Park); 1989 Jul; 3(7):56, 59. PubMed ID: 2701812
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical effects of P-100 (CSF-HU) in chronic neutropenia of childhood].
    Komiyama A; Ishiguro A; Akabane T; Tsuchida M; Tsukimoto I; Hanawa Y; Higuchi S; Matsuda I; Nakazawa S; Yamamoto M
    Rinsho Ketsueki; 1988 Sep; 29(9):1365-70. PubMed ID: 3063853
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical trials referral resource. Small-cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1990 Jan; 4(1):43-56. PubMed ID: 2168198
    [No Abstract]   [Full Text] [Related]  

  • 59. Colony-stimulating factors in the treatment of HIV-associated non-Hodgkin's lymphoma.
    Walsh C
    Oncology (Williston Park); 1989 Oct; 3(10):79-83; discussion 84-6. PubMed ID: 2701212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-infectious responses in Leishmania major-infected BALB/c mice injected with recombinant granulocyte-macrophage colony-stimulating factor.
    Solbach W; Greil J; Röllinghoff M
    Ann Inst Pasteur Immunol; 1987; 138(5):759-62. PubMed ID: 3326625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.